Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Oseltamivir is a potent neuraminidase inhibitor used for the treatment and prophylaxis of Influenza A and B. It works by preventing the release of viral particles from infected host cells.
Name
Oseltamivir
Raw Name
OSELTAMIVIR PHOSPHATE
Category
Other
Salt Form
Phosphate
Drug Count
9
Variant Count
124
Last Verified
February 17, 2026
RxCUI
312122, 1115698, 728109, 728113, 261315, 728111, 728115, 1115700
UNII
4A3O49NGEZ
About Oseltamivir
Oseltamivir is a potent neuraminidase inhibitor used for the treatment and prophylaxis of Influenza A and B. It works by preventing the release of viral particles from infected host cells.
Detailed information about Oseltamivir
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Oseltamivir.
Clinically, oseltamivir is classified as a prodrug. This means that the substance administered (oseltamivir phosphate) is relatively inactive until it is metabolized within the body—specifically in the liver—into its active form, oseltamivir carboxylate. As a neuraminidase inhibitor, it targets a specific protein on the surface of the influenza virus, which is essential for the virus's ability to spread within the respiratory tract. Your healthcare provider may prescribe this medication if you are at high risk for complications from the flu or if you have been in close contact with someone who is infected.
To understand how oseltamivir works, one must understand the life cycle of the influenza virus. When the flu virus infects a host cell in the respiratory tract, it uses the cell's machinery to create copies of itself. These new viral particles (virions) then gather at the surface of the host cell, ready to break away and infect neighboring healthy cells. However, these new virions are initially tethered to the host cell by sialic acid residues.
The influenza virus carries an enzyme called neuraminidase (the 'N' in H1N1 or H3N2). The primary job of neuraminidase is to act like molecular scissors, cleaving the sialic acid bonds and allowing the new viruses to escape the host cell. Oseltamivir works by binding to the active site of the neuraminidase enzyme. By inhibiting this enzyme, oseltamivir effectively 'traps' the new viral particles on the surface of the already-infected cell. This prevents the virus from spreading to other cells in the lungs and throat, thereby limiting the duration and severity of the infection. It is important to note that oseltamivir does not 'kill' the virus directly but rather halts its replication cycle, allowing the body's natural immune system to clear the existing infection more efficiently.
Oseltamivir phosphate is rapidly absorbed from the gastrointestinal tract following oral administration. It has a high oral bioavailability, with approximately 80% of the dose reaching the systemic circulation as the active metabolite, oseltamivir carboxylate. Interestingly, the absorption of oseltamivir is not significantly hindered by food; in fact, taking the medication with a light meal is often recommended to improve gastrointestinal tolerance and reduce the risk of nausea.
The active metabolite, oseltamivir carboxylate, is distributed widely throughout the body, including the upper and lower respiratory tracts, which are the primary sites of influenza infection. Its volume of distribution is approximately 23 to 26 liters in humans. Protein binding is remarkably low, with only about 3% of the active metabolite bound to human plasma proteins, suggesting that drug-drug interactions involving protein displacement are unlikely.
Oseltamivir is a prodrug that undergoes extensive conversion to its active form. This conversion is primarily mediated by hepatic esterases (enzymes in the liver). Unlike many other medications, oseltamivir is not significantly metabolized by the Cytochrome P450 (CYP) enzyme system. This is a critical clinical feature, as it reduces the likelihood of metabolic interactions with other drugs that are common CYP substrates.
The active metabolite is eliminated almost entirely by the kidneys through both glomerular filtration and active tubular secretion. The elimination half-life of oseltamivir carboxylate is approximately 6 to 10 hours in most healthy adults. Because the kidneys are the primary route of exit, patients with impaired renal function require careful dose adjustments to prevent drug accumulation and potential toxicity.
Oseltamivir is FDA-approved for several specific indications related to the influenza virus:
Off-label uses may include the treatment of avian influenza (bird flu) or other emerging viral strains, though these uses are guided by specific CDC (Centers for Disease Control and Prevention) and WHO (World Health Organization) protocols.
Oseltamivir is available in two primary oral formulations to accommodate different age groups and swallowing abilities:
> Important: Only your healthcare provider can determine if Oseltamivir is right for your specific condition. It is not a substitute for the annual flu vaccine, which remains the primary method of influenza prevention.
For the treatment of influenza in adults (18 years and older), the standard recommended dose is 75 mg twice daily (BID) for a total of 5 days. For the treatment to be most effective, the first dose should be initiated as soon as possible, ideally within 48 hours of the onset of symptoms.
For the prevention (prophylaxis) of influenza, the standard adult dose is 75 mg once daily (QD). When used for post-exposure prophylaxis (after contact with an infected individual), the duration is typically 10 days. During community outbreaks, your healthcare provider may recommend taking it for up to 6 weeks to provide continuous protection.
Oseltamivir is approved for the treatment of influenza in infants as young as 2 weeks old. Dosing in children is strictly weight-based:
For prophylaxis in children 1 year and older, the weight-based doses listed above are administered once daily rather than twice daily.
Because oseltamivir is primarily cleared by the kidneys, patients with reduced kidney function (measured by Creatinine Clearance, or CrCl) require modified dosing to avoid toxicity.
No dosage adjustment is typically required for patients with mild-to-moderate hepatic (liver) impairment. The safety and efficacy in patients with severe hepatic impairment have not been extensively studied.
No specific dose adjustments are required for geriatric patients unless there is evidence of significant renal impairment, which is common in older populations.
Oseltamivir can be taken with or without food. However, taking it with food (such as a glass of milk or a light snack) can significantly decrease the chance of experiencing stomach upset, nausea, or vomiting.
If you are using the oral suspension (liquid), ensure you use the specific oral dosing syringe provided by the pharmacy to measure the dose accurately. Household teaspoons are not accurate for medical dosing. If you have the capsules but cannot swallow them, your pharmacist may be able to provide instructions on opening the capsule and mixing the contents with a sweetened liquid, such as chocolate syrup or light brown sugar dissolved in water, to mask the bitter taste.
Storage: Capsules should be stored at room temperature (25°C/77°F). The reconstituted liquid suspension should be stored in the refrigerator but should not be frozen. If refrigeration is unavailable, the liquid can be stored at room temperature for up to 10 days.
If you miss a dose of oseltamivir, take it as soon as you remember. However, if it is within 2 hours of your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of side effects.
While reports of oseltamivir overdose are rare, symptoms may include severe nausea, vomiting, or dizziness. In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. There is no specific antidote for oseltamivir; treatment involves supportive care and monitoring of vital signs.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not stop taking the medication early, even if you feel better, as the full 5-day course is necessary to ensure the virus is adequately suppressed.
The most frequently reported side effects of oseltamivir involve the gastrointestinal system. These symptoms are generally mild to moderate and typically occur within the first two days of treatment.
These effects may occur in some patients but are generally not severe enough to warrant discontinuation of the drug:
While oseltamivir is generally well-tolerated, some patients may experience severe reactions.
> Warning: Stop taking Oseltamivir and call your doctor immediately if you experience any of the following:
Oseltamivir is intended for short-term use (typically 5 to 10 days). There are no well-documented long-term side effects associated with these short durations of therapy. However, repeated or prolonged use can lead to the development of viral resistance. This means the influenza virus may mutate so that oseltamivir is no longer effective against it. For this reason, oseltamivir should only be used when clinically necessary and as prescribed by a healthcare professional.
However, the FDA does require a prominent warning in the 'Warnings and Precautions' section regarding neuropsychiatric events. This warning was added following post-marketing reports, primarily from Japan, showing that pediatric patients were at an increased risk of confusion and self-harming behavior shortly after starting the medication. Healthcare providers and caregivers are advised to monitor patients closely for any signs of unusual behavior throughout the duration of treatment.
Report any unusual symptoms or changes in mood to your healthcare provider immediately. Your safety is the priority, and a medical professional can help determine if the symptoms are caused by the virus or the medication.
Oseltamivir is a prescription antiviral medication and should only be used under the guidance of a healthcare professional. It is important to understand that oseltamivir is not a 'cure' for the flu in the sense that it kills the virus instantly; rather, it shortens the duration of the illness and may prevent severe complications like pneumonia. It is also critical to remember that oseltamivir is only effective against influenza viruses; it does not treat the 'common cold,' bacterial infections, or other viral respiratory infections like COVID-19 or RSV.
As of 2026, there are no FDA black box warnings for oseltamivir. However, the absence of a black box warning does not mean the drug is without risk. The most significant safety concern remains the risk of neuropsychiatric events in pediatric and young adult populations.
Patients with influenza, including those receiving oseltamivir, may be at an increased risk for neuropsychiatric events such as delirium, hallucinations, and abnormal behavior. These events are most common in children and adolescents. Caregivers should monitor for signs of confusion, agitation, or self-injury. If these symptoms occur, contact a doctor immediately. It is often difficult to distinguish whether these behaviors are caused by the high fever associated with the flu (febrile delirium) or the medication itself.
Serious skin and hypersensitivity reactions, including anaphylaxis and serious skin reactions such as Stevens-Johnson Syndrome, have been reported. If you develop a skin rash, blisters, or swelling, stop the medication immediately and seek emergency care.
Oseltamivir has no effect on bacterial infections. The flu can sometimes lead to secondary bacterial infections (like bacterial pneumonia or ear infections). If your symptoms worsen or if a new fever develops after you initially started feeling better, consult your doctor, as you may require antibiotics.
The oral suspension formulation of oseltamivir contains sorbitol. Patients with rare hereditary fructose intolerance should be cautious, as the sorbitol content may cause gastrointestinal distress or other complications.
For most healthy patients taking a standard 5-day course, intensive laboratory monitoring is not required. However, in specific populations, the following may be monitored:
Oseltamivir is not generally known to cause significant impairment of motor skills or cognitive function. However, the influenza virus itself often causes severe fatigue, dizziness, and malaise (a general feeling of being unwell). Patients should assess how they feel before attempting to drive or operate heavy machinery.
There is no direct chemical interaction between oseltamivir and alcohol. However, alcohol can dehydrate the body and weaken the immune system, both of which can hinder your recovery from the flu. Furthermore, alcohol may exacerbate the gastrointestinal side effects (nausea/vomiting) of the medication. It is generally advised to avoid alcohol until you have fully recovered from the influenza infection.
There is no 'withdrawal syndrome' associated with stopping oseltamivir. However, if you stop the medication before completing the full 5-day course, the virus may begin to replicate again, potentially causing your symptoms to return or increasing the risk of developing drug-resistant viral strains. Always finish the entire prescription unless your doctor tells you otherwise due to a side effect.
> Important: Discuss all your medical conditions, especially kidney disease or heart conditions, with your healthcare provider before starting Oseltamivir.
There are no medications that are strictly 'contraindicated' (forbidden) for use with oseltamivir due to fatal chemical reactions. However, there is a significant interaction with the Live Attenuated Influenza Vaccine (LAIV), commonly known as the nasal spray flu vaccine (FluMist).
Probenecid is a medication often used to treat gout. It works by inhibiting certain transporters in the kidneys.
Drugs that are also eliminated through active kidney secretion might compete with oseltamivir for exit. Examples include Chlorpropamide, Methotrexate, and Phenylbutazone.
There are no known 'dangerous' food interactions with oseltamivir. Unlike some antibiotics, it does not interact with dairy products or calcium.
There is limited data on interactions between oseltamivir and herbal supplements.
Oseltamivir is not known to significantly interfere with common laboratory tests, such as basic metabolic panels, complete blood counts, or liver function tests. It does not affect the results of rapid influenza diagnostic tests (RIDTs), though the viral load may decrease quickly once treatment begins, potentially leading to a 'false negative' if the test is performed late in the treatment course.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even 'natural' products can influence how your body processes medication.
Oseltamivir is contraindicated in patients with a known serious hypersensitivity to oseltamivir phosphate or any component of the product.
These are conditions where the benefit of the drug must be carefully weighed against the risks:
There is no documented cross-sensitivity between oseltamivir and other classes of antivirals (like acyclovir for herpes or oseltamivir's relative, zanamivir). Zanamivir is an inhaled neuraminidase inhibitor; while it has a similar mechanism, its chemical structure is different. However, if a patient has a history of severe 'class-wide' reactions to neuraminidase inhibitors, healthcare providers will proceed with extreme caution.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous drug allergies, before prescribing Oseltamivir to ensure it is safe for you.
Oseltamivir is generally considered the preferred antiviral for the treatment of influenza in pregnant women.
Oseltamivir and its active metabolite are excreted in human breast milk, but the levels are extremely low.
Oseltamivir is approved for the treatment of influenza in pediatric patients from birth (specifically 2 weeks of age and older) and for prophylaxis in children 1 year and older.
In clinical trials, the safety and efficacy of oseltamivir in patients over 65 were similar to those in younger adults.
Renal function is the most critical determinant of oseltamivir safety.
In patients with mild to moderate hepatic impairment, the conversion of the prodrug to the active metabolite remains sufficient. No dose adjustment is necessary. For patients with severe liver failure (e.g., Child-Pugh Class C), oseltamivir should be used with caution as data is limited.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or have any history of kidney disease.
Oseltamivir is a potent and selective inhibitor of the neuraminidase enzyme found on the surface of Influenza A and B viruses. At the molecular level, the active metabolite (oseltamivir carboxylate) mimics the transition state of sialic acid. It binds with high affinity to the highly conserved active site of the viral neuraminidase. By occupying this site, it prevents the enzyme from cleaving terminal sialic acid residues from glycoproteins on the surface of infected cells. This cleavage is a mandatory step for the release of newly formed virions. Without it, the virus remains clumped at the cell membrane, unable to spread and continue the infection cycle.
The relationship between the concentration of oseltamivir and its antiviral effect is well-established. The 'inhibitory concentration' (IC50) for influenza neuraminidase is in the low nanomolar range.
| Parameter | Value |
|---|---|
| Bioavailability | ~80% (as active metabolite) |
| Protein Binding | ~3% (active metabolite) |
| Half-life | 6–10 hours (active metabolite) |
| Tmax | 2–3 hours (active metabolite) |
| Metabolism | Hepatic esterases (not CYP450) |
| Excretion | Renal >99% |
Oseltamivir is a Neuraminidase Inhibitor. It is therapeutically categorized as an Antiviral agent. Related medications in this class include Zanamivir (Relenza), Peramivir (Rapivab), and Laninamivir. It is distinct from the older class of flu drugs, the adamantanes (Amantadine/Rimantadine), which are no longer recommended due to widespread viral resistance.
Medications containing this ingredient
Common questions about Oseltamivir
Oseltamivir is primarily used for the treatment and prevention of the flu (Influenza A and B). When used for treatment, it is intended for patients who have had symptoms for two days or less, helping to shorten the duration of the illness and reduce the risk of complications like pneumonia. It is also used as a preventative measure for people who have been exposed to the flu, such as those living with an infected person. It is important to note that Oseltamivir does not treat the common cold or other viral infections like COVID-19. It is available by prescription only and comes in capsule and liquid forms.
The most common side effects of Oseltamivir are nausea and vomiting, which occur in about 10% to 15% of patients. These symptoms usually happen within the first two days of starting the treatment and often go away as you continue the medication. Other frequent side effects include headache and occasional stomach pain. To help reduce the chance of stomach upset, healthcare providers recommend taking the medication with a small snack or a glass of milk. While these side effects are common, they are usually mild and do not require stopping the medication. Always talk to your doctor if these symptoms become severe or persistent.
There is no known direct chemical interaction between Oseltamivir and alcohol that would cause a dangerous reaction. However, drinking alcohol while you have the flu is generally not recommended because alcohol can dehydrate you and suppress your immune system, making it harder for your body to recover. Additionally, both Oseltamivir and alcohol can cause nausea and stomach upset, so combining them may make these side effects worse. It is best to focus on staying hydrated with water, juice, or electrolyte drinks until you are fully recovered. If you choose to drink, it is important to do so only in moderation and after consulting your physician.
Oseltamivir is generally considered safe and is the preferred treatment for pregnant women who have the flu. Because pregnant women are at a much higher risk for severe flu complications, health organizations like the CDC and ACOG recommend its use during pregnancy. Studies involving thousands of pregnant women have not shown an increased risk of birth defects or other pregnancy problems. If you are pregnant and develop flu-like symptoms, you should contact your doctor immediately to discuss starting treatment. Early treatment is crucial for protecting both the mother and the developing baby. Your doctor will weigh the benefits of the medication against any potential risks.
Oseltamivir begins working at the molecular level within a few hours of the first dose by preventing the virus from spreading to new cells. However, you may not feel a significant improvement in your symptoms for 24 to 48 hours. Clinical studies show that, on average, Oseltamivir shortens the duration of the flu by about one to one and a half days. It is most effective when started as soon as possible after symptoms begin. Even if you start feeling better quickly, it is essential to complete the full 5-day course of treatment. This ensures that the virus is fully suppressed and reduces the risk of the infection returning.
While you can technically stop taking Oseltamivir without experiencing withdrawal symptoms, it is highly discouraged to stop before the full 5-day course is finished. Stopping the medication early can allow the remaining flu virus to start replicating again, which may cause your symptoms to return or worsen. Furthermore, incomplete treatment can contribute to the development of drug-resistant strains of the virus, making the medication less effective for you and others in the future. If you are experiencing bothersome side effects that make you want to stop, contact your healthcare provider first. They may suggest ways to manage the side effects so you can finish your prescription safely.
If you miss a dose of Oseltamivir, you should take it as soon as you remember. However, if your next scheduled dose is less than 2 hours away, you should skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for a missed one, as this can increase your risk of side effects like nausea and vomiting. After taking the missed dose or skipping it, continue with your regular dosing schedule until the prescription is finished. If you miss several doses in a row, contact your doctor for further guidance. Keeping a consistent schedule helps maintain the right amount of medicine in your body to fight the virus.
No, Oseltamivir is not known to cause weight gain. It is an antiviral medication taken for a very short duration, typically 5 to 10 days, which is not long enough to affect your body weight through metabolic or hormonal changes. In fact, many people with the flu actually lose a small amount of weight because the illness often causes a loss of appetite and increased calorie burning due to fever. If you notice significant weight changes while taking this medication, it is likely due to other factors or the illness itself rather than the drug. If you have concerns about weight changes or your appetite during recovery, discuss them with your healthcare provider.
Oseltamivir can be taken with most other medications because it does not interact with the common liver enzymes that process many drugs. However, there is a specific interaction with the nasal spray flu vaccine (FluMist); you should not take Oseltamivir within 2 weeks before or 48 hours after receiving this vaccine. It is generally safe to take Oseltamivir with over-the-counter fever reducers like acetaminophen (Tylenol) or ibuprofen (Advil). You should always provide your doctor or pharmacist with a full list of all prescriptions, over-the-counter drugs, and supplements you are taking. This allows them to check for any specific concerns based on your individual health profile.
Yes, Oseltamivir is available as a generic medication. The brand name version is known as Tamiflu, but several manufacturers now produce generic oseltamivir phosphate in both capsule and oral suspension forms. Generic versions are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name drug. They are also held to the same quality and safety standards. Choosing the generic version can often save you money while providing the same clinical benefits for treating or preventing the flu. Check with your pharmacist to see which version is covered by your insurance or available at the best price.